Clinical Trials Sponsored by AllerGen NCE Inc.

Total 1310 results

NSABP Foundation Inc
National Cancer Institute (NCI)

Completed

Diagnostic Procedures in Detecting Tumor Cells in the Bone Marrow of Patients Undergoing Surgery for Stage I, Stage II, or Stage IIIA Breast Cancer

Breast Cancer

United States, Canada
XEME Biopharma Inc.
National Cancer Institute (NCI)

Active, not recruiting

Vaccine Therapy for Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia (CLL)

Chronic Lymphocytic Leukemia (CLL)

United States
NSABP Foundation Inc
National Cancer Institute (NCI)

Completed

Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Positive Breast Cancer

Breast Cancer

United States
NSABP Foundation Inc
National Cancer Institute (NCI)

Unknown

Chemotherapy With or Without Bevacizumab in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer That Can Be Removed By Surgery

Breast Cancer

United States, Canada, Puerto Rico
Blaze Bioscience Inc.
National Cancer Institute (NCI)

Withdrawn

Safety Study of BLZ-100 in Adult Subjects With Sarcoma Undergoing Surgery

Sarcoma, Soft Tissue

United States
NSABP Foundation Inc
National Cancer Institute (NCI)

Unknown

Study of Blood Samples From High-Risk Postmenopausal Women Who Received Treatment on Breast Cancer Prevention Clinical Trials NSABP-P-1 or NSABP-P-2

Breast Cancer
Spectrum Pharmaceuticals, Inc
National Cancer Institute (NCI)

Terminated

Safety Study of PT-523 in Cancer Patients to Treat Solid Tumors Including a Preliminary Assessment of Effectiveness

Neoplasms

United States
PDL BioPharma, Inc.

Unknown

Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Lymphoma

United States
Astex Pharmaceuticals, Inc.

Unknown

Nitrocamptothecin Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer

Pancreatic Cancer

United States
Astex Pharmaceuticals, Inc.

Completed

Nitrocamptothecin in Treating Patients With Metastatic Melanoma

Melanoma (Skin)

United States
Delcath Systems Inc.
National Cancer Institute (NCI)

Completed

Hepatic Arterial Infusion of Melphalan With Hepatic Perfusion in Treating Patients With Unresectable Liver Cancer

Cancer

United States
Astex Pharmaceuticals, Inc.

Terminated

MP470 in Treating Patients With Unresectable or Metastatic Solid Tumor or Lymphoma

Lymphoma | Unspecified Adult Solid Tumor, Protocol Specific

United States
National Cancer Institute (NCI)
NSABP Foundation Inc

Completed

Hepatic Arterial Infusion Plus Chemotherapy in Treating Patients With Colorectal Cancer Metastatic to the Liver

Liver Metastases | Stage IV Colon Cancer | Stage IV Rectal Cancer | Recurrent Colon Cancer | Recurrent Rectal Cancer | Adenocarcinoma of the Rectum | Adenocarcinoma of the Colon

United States
NSABP Foundation Inc
National Cancer Institute (NCI)

Completed

Fluorouracil, Semustine, and Vincristine Compared With BCG in Treating Patients With Dukes' B or Dukes' C Colon Cancer That Has Been Removed By Surgery

Colorectal Cancer
Pacira Pharmaceuticals, Inc

Unknown

Chemotherapy in Treating Young Patients With Recurrent or Refractory Meningeal Leukemia, Lymphoma, or Solid Tumors

Lymphoma | Unspecified Childhood Solid Tumor, Protocol Specific | Leukemia | Brain and Central Nervous System Tumors

Canada, United States
NSABP Foundation Inc
National Cancer Institute (NCI)

Completed

Chemotherapy in Treating Women With Breast Cancer That Can Be Surgically Removed

Breast Cancer

United States, Canada
Shionogi
National Institute of Allergy and Infectious Diseases (NIAID)

Active, not recruiting

A Study to Compare S-217622 With Placebo in Non-Hospitalized Participants With COVID-19 (SCORPIO-HR)

SARS-CoV-2 Infection

United States, India, Uganda, Poland, Philippines, Thailand, Pakistan, South Africa, Argentina, Brazil, Colombia, Ghana, Japan, Kenya, Malawi, Mexico, Turkey
Venatorx Pharmaceuticals, Inc.
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

VNRX-5024 Safety and PK in Healthy Adult Volunteers

Healthy Subjects

Netherlands
Melinta Therapeutics, Inc.
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Efficacy and Safety Study of Oral Solithromycin Compared to Intramuscular Ceftriaxone Plus Oral Azithromycin in the Treatment of Patients With Gonorrhea (SOLITAIRE-U)

Uncomplicated Urogenital Gonorrhea

United States, Australia
Venatorx Pharmaceuticals, Inc.
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

VNRX-5133 SAD/MAD Safety and PK in Healthy Adult Volunteers

Bacterial Infections

United States
National Institute of Allergy and Infectious Diseases...
Genentech, Inc.; MicroGeneSys Inc (nka Protein Sciences Corporation)

Completed

A Placebo-Controlled, Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of Recombinant Envelope Proteins of HIV-1 gp160 and gp120 in Children >= 1 Month Old With Asymptomatic HIV Infection

HIV Infections

United States, Puerto Rico
Alessa Therapeutics Inc.
National Cancer Institute (NCI)

Recruiting

Bicalutamide Implants (Biolen) With Radiation Therapy in Patients With Localized Prostate Cancer (BiolenRT)

Prostate Adenocarcinoma

United States
Envivo Bio Inc
National Cancer Institute (NCI)

Completed

Evaluation of the CapScan Device to Measure the Metabolism of Sulfasalazine

Healthy

United States
DEKK-TEC, Inc.
National Cancer Institute (NCI)

Completed

DM-CHOC-PEN Plus Radiation for Brain Tumors

Advanced Cancer

United States
NSABP Foundation Inc
National Cancer Institute (NCI)

Completed

Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer

Breast Cancer

United States, Canada, Puerto Rico
Delcath Systems Inc.
National Cancer Institute (NCI)

Completed

Hepatic Arterial Infusion With Melphalan Compared With Standard Therapy in Treating Patients With Unresectable Liver Metastases Due to Melanoma

Metastatic Cancer | Intraocular Melanoma | Melanoma (Skin)

United States
NSABP Foundation Inc
National Cancer Institute (NCI)

Completed

Doxorubicin and Cyclophosphamide Plus Paclitaxel With or Without Trastuzumab in Treating Women With Node-Positive Breast Cancer That Overexpresses HER2

Breast Cancer

United States, Canada
DEKK-TEC, Inc.
National Cancer Institute (NCI)

Completed

Study of 4-Demethylcholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) in Patients With Advanced Cancer (DM-CHOC-PEN)

Advanced Cancer | Brain Involvement

United States
DEKK-TEC, Inc.
National Cancer Institute (NCI)

Completed

Study of 4-Demethylcholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) in Patients With Advanced Cancer" (DM-CHOC-PEN)

Advanced Cancer

United States
Acrotech Biopharma Inc.
National Cancer Institute (NCI)

Completed

To Evaluate the Safety, Activity and Pharmacokinetics of Marqibo in Children and Adolescents With Refractory Cancer

Sarcoma | Lymphoma | Leukemia | Neuroblastoma | Brain Tumors | Wilms Tumor

United States
National Cancer Institute (NCI)
NSABP Foundation Inc

Completed

Fluorouracil, Leucovorin, and Oxaliplatin With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II or Stage III Colon Cancer

Colon Adenocarcinoma | Stage IIIA Colon Cancer AJCC v7 | Stage IIIB Colon Cancer AJCC v7 | Stage IIIC Colon Cancer AJCC v7 | Stage IIA Colon Cancer AJCC v7 | Stage IIB Colon Cancer AJCC v7 | Stage IIC Colon Cancer AJCC v7

United States
Mercator MedSystems, Inc.
National Cancer Institute (NCI)

Completed

Broncho-Adventitial Delivery of Paclitaxel to Extend Airway Patency in Malignant Airway Obstruction Patients (BROADWAY)

Malignant Airway Obstruction Secondary to Non-small Cell Lung Cancer

United States
NSABP Foundation Inc
National Cancer Institute (NCI)

Completed

Surgery to Remove Sentinel Lymph Nodes With or Without Removing Lymph Nodes in the Armpit in Treating Women With Breast Cancer

Breast Cancer

Canada, United States, Puerto Rico
Astex Pharmaceuticals, Inc.

Completed

Nitrocamptothecin in Treating Patients With Recurrent Non-small Cell Lung Cancer

Lung Cancer

United States
Astex Pharmaceuticals, Inc.

Completed

Nitrocamptothecin in Treating Patients With Locally Recurrent or Metastatic Breast Cancer

Breast Cancer

United States
Astex Pharmaceuticals, Inc.

Unknown

Nitrocamptothecin in Treating Patients With Advanced or Recurrent Colorectal Cancer

Colorectal Cancer

United States
Astex Pharmaceuticals, Inc.

Unknown

Nitrocamptothecin Compared With Other Chemotherapy in Treating Patients With Recurrent or Refractory Cancer of the Pancreas

Pancreatic Cancer

United States
Astex Pharmaceuticals, Inc.

Unknown

Nitrocamptothecin in Treating Patients With Locally Advanced or Metastatic Stomach Cancer That Cannot Be Removed During Surgery

Gastric Cancer | Esophageal Cancer

United States
NSABP Foundation Inc
National Cancer Institute (NCI)

Terminated

Oxaliplatin and Capecitabine With or Without an Hepatic Arterial Infusion With Floxuridine in Treating Patients Who Are Undergoing Surgery and/or Ablation for Liver Metastases Due to Colorectal Cancer

Colorectal Cancer | Metastatic Cancer

United States
Oncothyreon Canada Inc.

Completed

Vaccine Therapy in Treating Women With Metastatic Breast Cancer

Breast Cancer

Canada
NSABP Foundation Inc
National Cancer Institute (NCI)

Withdrawn

Studying Biological Markers of Fatigue in Women With Residual Invasive Breast Cancer Enrolled on Clinical Trial NSABP-B-45

Breast Cancer | Fatigue
NSABP Foundation Inc
National Cancer Institute (NCI)

Terminated

Celecoxib in Preventing Polyps in Patients Who Have Undergone Surgery for Stage I Colon Cancer

Colorectal Cancer

United States
Reveal Pharmaceuticals Inc.
National Cancer Institute (NCI)

Recruiting

Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent

Central Nervous System (CNS) Lesions

United States
NSABP Foundation Inc
National Cancer Institute (NCI)

Completed

Combination Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA (cT1-3, N0-1, M0) Breast Cancer and Positive Axillary Lymph Nodes

Breast Cancer

United States, Canada
Vergent Bioscience, Inc.
National Cancer Institute (NCI)

Completed

Phase 2 Study of VGT-309 in Lung Cancer

Lung Cancer

United States
Leuko Labs, Inc.
National Cancer Institute (NCI)

Completed

PC001- A Study to Evaluate the Usability of PointCheck

Neoplasms | Neutropenia

United States
Klein Buendel, Inc.
National Cancer Institute (NCI)

Completed

Virtual Sun Safe Workplaces Ph I (SSW Works)

Skin Cancer

United States
NSABP Foundation Inc
National Cancer Institute (NCI)

Completed

Factors Influencing Decision-Making About the Use of Chemoprevention in Women at Increased Risk for Breast Cancer

Breast Cancer

United States
Aadi Bioscience, Inc.
National Cancer Institute (NCI)

Completed

Phase 1/2 Study of ABI-009 in Nonmuscle Invasive Bladder Cancer

Non-muscle Invasive Bladder Cancer (NMIBC)

United States
NSABP Foundation Inc
National Cancer Institute (NCI)

Unknown

Study of Biomarkers Associated With Fatigue in Patients With Early-Stage Breast Cancer Treated With Metformin or Placebo on NCIC-CTG-MA.32

Depression | Breast Cancer | Fatigue | Sleep Disorders

United States, Canada

Clinical Trials Sponsored by AllerGen NCE Inc.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ukraine

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations